Amalgamated Bank Sells 76,406 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Amalgamated Bank cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 35.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 141,191 shares of the pharmacy operator's stock after selling 76,406 shares during the quarter. Amalgamated Bank's holdings in Walgreens Boots Alliance were worth $1,265,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. New Covenant Trust Company N.A. purchased a new position in shares of Walgreens Boots Alliance during the first quarter valued at $35,000. Iron Horse Wealth Management LLC grew its stake in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 1,300 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 1,081 shares during the period. Continuum Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 1,020 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth approximately $34,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded down $0.20 during midday trading on Thursday, reaching $8.83. The stock had a trading volume of 13,631,056 shares, compared to its average volume of 17,324,646. The stock has a market capitalization of $7.63 billion, a P/E ratio of -0.90, a PEG ratio of 1.18 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The firm's fifty day simple moving average is $9.19 and its 200-day simple moving average is $11.99.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the previous year, the company posted $0.67 earnings per share. The firm's revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.33%. Walgreens Boots Alliance's dividend payout ratio is -9.99%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an "in-line" rating in a research note on Wednesday, October 16th. UBS Group upped their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a research note on Thursday, October 17th. Morgan Stanley reduced their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a research report on Friday, October 11th. Jefferies Financial Group dropped their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a research report on Wednesday, October 23rd. Finally, Bank of America reduced their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an "underperform" rating for the company in a report on Wednesday, September 4th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of "Hold" and a consensus price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.